The Cash Component Of The Aggregate Merger Consideration Will Be A Base Cash Amount Of $9,005,000 (Consisting Of A Value Of $15M Minus The $5,995,000 Advanced To Kineta Under The Exclusivity And Right Of First Offer Agreement)

BenzingaDec 12 22:49

Kineta Merges With TuHURA to Enhance Cancer Treatment

TipRanksDec 12 22:28

TuHURA Biosciences To Acquire Kineta, Cash Component Of Merger Consideration Will Be Base Cash Amount Of $9,005,000 Less The Sum Of Kineta's Working Capital Deficit At Closing; In Connection With Merger, TuHURA And Kineta Entered Clinical Trial...

BenzingaDec 12 21:51

Express News | Tuhura Biosciences Inc: Enters Into Definitive Merger Agreement to Acquire Kineta, Inc.

BreakingsDec 12 21:46

Kineta and TuHURA Enter Acquisition Agreement

TipRanksNov 25 22:27

Express News | Kineta Inc - Favorable Tolerability and Toxicity Profile in Both Arms

BreakingsNov 8 22:00